跳至主要内容
临床试验/IRCT20240220061057N1
IRCT20240220061057N1招募中2 期

Study the expression of CCR2, PPAR-G and NF-?B in peripheral blood leukocytes, oxidative stress and seizure frequency in drug-resistant epileptic patients, after combination therapy with High DHA/EPA PUFA and Ascorbic acid

Ardabil University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Epileptic patients who take at least two antiepileptic drugs but have had at least one seizure in the last 6 months.
  • Patients are at least 18 years old
  • Willingness to participate in the study

排除标准

  • chronic kidney disease
  • history of MI or vascular interventions
  • history of renal stone
  • use of anticoagulants
  • history of allergy to ascorbic acid or DHA/EPA PUFA
  • history of familial or acquired dyslipidemia
  • The patient unwillingness to continue the combined treatment

研究者

相似试验